<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03920150</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00987</org_study_id>
    <nct_id>NCT03920150</nct_id>
  </id_info>
  <brief_title>Vitamin D 24'000 IU for Oral Intermittent Supplementation</brief_title>
  <acronym>DO-IT</acronym>
  <official_title>Vitamin D 24'000 IU for Oral Intermittent Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficiency (defined as 25(OH)-vitamin D serum level &lt;50 nmol/l) is cured with oral
      supplementation. National guidelines recommend the administration of 800 IU cholecalciferol
      daily for an effective treatment, especially during the winter (poor sun exposition).
      Cumulative intermittent administration monthly (24'000 IU) or weekly (5'600 IU) is possible.
      Commercially available intermittent pharmaceutical forms in Switzerland are liquid (oily or
      alcoholic solution). The study aims to compare the rise of vitamin D3 levels after treatment
      between newly developed soft capsules and monthly solution (primary outcome), and to evaluate
      the effect of a loading dose (without infringing the cumulative maximal dose of 4'000 IU per
      day) on the achievement of optimal values &gt;75 nmol/l (secondary outcome). The investigators
      will use newly developed soft capsules and alcoholic solution, which are commercially
      available in Switzerland.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Group Control, Alcoholic Drinking Solution: 5 ml of an alcoholic drinking solution with
      24'000 IU vitamin D p.o. once a month for 3 months (3 doses).

      Group IMP, Capsules: one capsule with 24'000 IU vitamin D p.o. once a month for 3 months (3
      doses).

      Group IMP + loading dose, Loading Dose: one capsule with 24'000 IU vitamin D p.o. once a week
      during an individually calculated number of weeks.

      All 3 groups: Measurement of vitamin D in serum before therapy and one week after the last
      dose.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 30, 2019</start_date>
  <completion_date type="Actual">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">May 31, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patient will be recruited by their general practitioner. Patients will be randomly assigned to be supplemented with monthly solution (control group), monthly capsules (IMP group) or weekly capsules after calculation of a individual loading dose (IMP + loading dose group).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum level of vitamin D</measure>
    <time_frame>3 months of treatment</time_frame>
    <description>Level of serum vitamin D after 3 month treatment compared to baseline value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum level of vitamin D after loading dose</measure>
    <time_frame>up to 4 months of treatment</time_frame>
    <description>Level of serum vitamin D &gt; 75 nmol/l after an individual number of treatment weeks, calculated with a loading dose formula.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Drug Reactions</measure>
    <time_frame>3 months of treatment</time_frame>
    <description>Number and severity of adverse drug reactions during treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to medication</measure>
    <time_frame>3 months of treatment</time_frame>
    <description>Taking adherence: (number of doses taken) divided by (number of doses prescribed) x 100.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 ml alcoholic solution containing 24'000 IU vitamin D for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin D oily capsules containing 24'000 IU vitamin D for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IMP + loading dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin D oily capsules containing 24'000 IU vitamin D for an individual number of weeks calculated with the formula: 40 x (100 - actual value [nmol/l] x body weight [kg] / 24'000 IU.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Patient will be treated with 3 doses of alcoholic solution for 3 months.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Vi-De 3 Monatsdosis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D oily capsules</intervention_name>
    <description>Patient will be treated with 3 capsules for 3 months.</description>
    <arm_group_label>IMP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D oily capsules</intervention_name>
    <description>Patient will be treated with weekly capsules for an individually calculated number of weeks.</description>
    <arm_group_label>IMP + loading dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  vitamin D deficiency by serum level &lt;50 nmol/l

        Exclusion Criteria:

          -  hypercalcaemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kurt E Hersberger, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Pharmaceutical Care Research Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pharmaceutical Care Research Group</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 12, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2019</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>optimal vitamin D value</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

